Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease

Journal of the American College of Cardiology

Volumn 65, Issue 3, 2015, Pages 270-277

  Rosenson, Robert S ^a   Kent, Shia T ^b   Brown, Todd M ^c   Farkouh, Michael E ^a,d   Levitan, Emily B ^b   Yun, Huifeng ^b   Sharma, Pradeep ^b   Safford, Monika M ^c   Kilgore, Meredith ^b   Muntner, Paul ^b   Bittner, Vera ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

coronary artery disease; drug use; hydroxymethylglutaryl CoA reductase inhibitors; secondary prevention

Indexed keywords

ATORVASTATIN; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICARE; RETROSPECTIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY DISEASE; DOSE RESPONSE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; SECONDARY PREVENTION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG PRESCRIPTIONS; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICARE; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; UNITED STATES;

EID: 84921341699     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.09.088     Document Type: Article

References (28)

1. C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
2. J.C. LaRosa, S.M. Grundy, and D.D. Waters Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435
3. J.C. LaRosa, S.M. Grundy, and J.J. Kastelein Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study) Am J Cardiol 100 2007 747 752
4. N.J. Stone, J. Robinson, and A.H. Lichtenstein 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2889 2934
5. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction J Am Coll Cardiol 50 2007 e1 e157
6. M.T. Roe, J.C. Messenger, and W.S. Weintraub Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention J Am Coll Cardiol 56 2010 254 263
7. E.D. Peterson, B.R. Shah, and L. Parsons Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006 Am Heart J 156 2008 1045 1055
8. S.V. Arnold, J.A. Spertus, and F.A. Masoudi Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction J Am Coll Cardiol 62 2013 1791 1801
9. B. Ziaeian, K.L. Araujo, P.H. Van Ness, and L.I. Horwitz Medication reconciliation accuracy and patient understanding of intended medication changes on hospital discharge J Gen Intern Med 27 2012 1513 1520
10. J.R. Pippins, T.K. Gandhi, and C. Hamann Classifying and predicting errors of inpatient medication reconciliation J Gen Intern Med 23 2008 1414 1422
11. A.N. Meguerditchian, S. Krotneva, K. Reidel, A. Huang, and R. Tamblyn Medication reconciliation at admission and discharge: a time and motion study BMC Health Serv Res 13 2013 485
12. H. Halapy, and H. Kertland Ascertaining problems with medication histories Can J Hosp Pharm 65 2012 360 367
13. S.K. Mueller, K.C. Sponsler, S. Kripalani, and J.L. Schnipper Hospital-based medication reconciliation practices: a systematic review Arch Intern Med 172 2012 1057 1069
14. G.G. Schwartz, A.G. Olsson, and M.D. Ezekowitz Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial JAMA 285 2001 1711 1718
15. J.A. de Lemos, M.A. Blazing, and S.D. Wiviott Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316
16. B. Pitt, J. Loscalzo, J. Monyak, E. Miller, and J. Raichlen Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study) Am J Cardiol 109 2012 1239 1246
17. S. Schneeweiss, and M. Maclure Use of comorbidity scores for control of confounding in studies using administrative databases Int J Epidemiol 29 2000 891 898
18. P.S. Romano, L.L. Roos, and J.G. Jollis Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives J Clin Epidemiol 46 1993 1075 1079 discussion 1081-90
19. A.G. Olsson, G.G. Schwartz, M. Szarek, D. Luo, and M.J. Jamieson Effects of high-dose atorvastatin in patients > or = 65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering [MIRACL] study) Am J Cardiol 99 2007 632 635
20. S. Acharjee, J. Qin, S.A. Murphy, C. McCabe, and C.P. Cannon Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial) Am J Cardiol 105 2010 619 623
21. S.C. Smith Jr., E.J. Benjamin, and R.O. Bonow AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation J Am Coll Cardiol 58 2011 2432 2446
22. B. Pitt, J. Loscalzo, J. Ycas, and J.S. Raichlen Lipid levels after acute coronary syndromes J Am Coll Cardiol 51 2008 1440 1445
23. E.A. Coleman, S.J. Min, A. Chomiak, and A.M. Kramer Posthospital care transitions: patterns, complications, and risk identification Health Serv Res 39 2004 1449 1465
24. A.J. Forster, H.J. Murff, J.F. Peterson, T.K. Gandhi, and D.W. Bates The incidence and severity of adverse events affecting patients after discharge from the hospital Ann Intern Med 138 2003 161 167
25. A.J. Forster, H.J. Murff, J.F. Peterson, T.K. Gandhi, and D.W. Bates Adverse drug events occurring following hospital discharge J Gen Intern Med 20 2005 317 323
26. S. Kripalani, F. LeFevre, C.O. Phillips, M.V. Williams, P. Basaviah, and D.W. Baker Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care JAMA 297 2007 831 841
27. C. Moore, T. McGinn, and E. Halm Tying up loose ends: discharging patients with unresolved medical issues Arch Intern Med 167 2007 1305 1311
28. C. Moore, J. Wisnivesky, S. Williams, and T. McGinn Medical errors related to discontinuity of care from an inpatient to an outpatient setting J Gen Intern Med 18 2003 646 651